Increasing the Removal of Protein-Bound Solutes During Extended Hours Hemodialysis

NCT ID: NCT01892839

Last Updated: 2015-07-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-07-31

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hemodialysis keeps patients with renal failure alive but does not restore normal health. Retention of chemicals that bind to plasma proteins and are therefore poorly removed by dialysis may contribute to ill health in patients receiving conventional treatment. This proposal will test the effect of a new method designed to improve the removal of protein-bound solutes during dialysis. The effects on blood chemical levels of two different dialysis prescriptions will be tested in patients already undergoing nocturnal in-center hemodialysis three times weekly.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End Stage Renal Failure on Dialysis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

high dialysate flow, larger dialyzer

high dialysate flow, larger dialyzer

Group Type EXPERIMENTAL

high dialysate flow, larger dialyzer

Intervention Type OTHER

The subject will receive dialysis on the usual schedule and for the usual time but with a higher than usual dialysate flow and large dialyzer.

low dialysate flow, smaller dialyzer

low dialysate flow, smaller dialyzer

Group Type ACTIVE_COMPARATOR

low dialysate flow, smaller dialyzer

Intervention Type OTHER

The subject will receive dialysis on the usual schedule and for the usual time but with a lower than usual dialysate flow and small dialyzer.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

low dialysate flow, smaller dialyzer

The subject will receive dialysis on the usual schedule and for the usual time but with a lower than usual dialysate flow and small dialyzer.

Intervention Type OTHER

high dialysate flow, larger dialyzer

The subject will receive dialysis on the usual schedule and for the usual time but with a higher than usual dialysate flow and large dialyzer.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* stable on nocturnal in-center dialysis located close to Stanford University and VA Palo Alto

Exclusion Criteria

* recent use of antibiotics
* gastrointestinal disease
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Palo Alto Veterans Institute for Research

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Timothy W Meyer, MD

Role: PRINCIPAL_INVESTIGATOR

PAIRE

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Satellite Redwood City

Redwood City, California, United States

Site Status RECRUITING

Stanford University

Stanford, California, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

tim meyer, md

Role: CONTACT

650-852-3314

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tim Meyer, MD

Role: primary

650-852-3314

Orlando Camacho, MD

Role: backup

650-852-3314

Timothy Meyer, MD

Role: primary

650-852-3314

Orlando Camacho, MD

Role: backup

650-852-3314

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MEY0026APR

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Developing Tools for Dialysis Decision Support
NCT06597279 ACTIVE_NOT_RECRUITING NA